You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR CANNABIDIVARIN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Cannabidivarin

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02365610 ↗	A Study of GWP42006 in People With Focal Seizures - Part B	Completed	GW Research Ltd	Phase 2	To investigate the potential antiepileptic effects of GWP42006 as add-on therapy in subjects with inadequately controlled focal seizures.
NCT02369471 ↗	A Study of GWP42006 in People With Focal Seizures - Part A	Completed	GW Research Ltd	Phase 2	To evaluate the pharmacokinetics, safety and tolerability of GWP42006 compared with placebo, in the presence of other antiepileptic drugs (AEDs).
NCT03202303 ↗	Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)	Recruiting	GW Pharmaceuticals Ltd.	Phase 2	This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.
NCT03202303 ↗	Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)	Recruiting	United States Department of Defense	Phase 2	This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.
NCT03202303 ↗	Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)	Recruiting	Montefiore Medical Center	Phase 2	This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.
NCT03537950 ↗	Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder	Unknown status	King's College London	N/A	This study investigates brain response to single acute dose of cannabidiol, cannabidivarin, and placebo in healthy men with and without autism spectrum disorder
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Cannabidivarin

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Autism Spectrum Disorder	3
Epilepsy	2
Focal Seizures	2
Attention Deficit	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Disease	3
Child Development Disorders, Pervasive	3
Autistic Disorder	3
Autism Spectrum Disorder	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Cannabidivarin

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	6
United Kingdom	3
Spain	2
Czech Republic	2
Hungary	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
New York	2
Florida	1
Ohio	1
Massachusetts	1
Kentucky	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Cannabidivarin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	6
N/A	1
Early Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Recruiting	3
Completed	2
Not yet recruiting	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cannabidivarin

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
GW Research Ltd	3
GW Pharmaceuticals Ltd.	2
Montefiore Medical Center	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Other	6
Industry	5
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.